Breaking news – Pagina 7 – AMD

Breaking news

Gennaio 22, 2026 Alice Lione

A comparison of diet and exercise during pregnancy in women with and without type 1 diabetes followed in the environmental determinants of islet autoimmunity (ENDIA) study

Thomson RL, Martin G, Brown JD, et al.
Diabetes Care. Pub. online 16 Jan 2026.

Leggi

Gennaio 22, 2026 Alice Lione

Sodium glucose transporter 2 inhibitor exposure and the risk of congenital malformations: nationwide birth cohort study

Jang M, Kim M, Suh HS
Nutr Metab Cardiovasc Dis. Pub. online 19 Jan 2026.

Leggi

Gennaio 22, 2026 Alice Lione

Medial arterial calcification of the foot arteries is associated with incident cardiovascular events or all-cause mortality in patients with diabetes-related foot ulceration

Lan NSR, Hiew J, Chen P, et al.
Diabetes Res Clin Pract. Pub. online 15 Jan 2026.

Leggi

Gennaio 20, 2026 Alice Lione

Socioeconomic and structural barriers to addressing obesity in communities: a scientific statement from the American Heart Association

Chung ST, Harrington J, Kandula NR, et al.
Circulation. Pub. online 15 Jan 2026.

Leggi

Gennaio 20, 2026 Alice Lione

2025 U.S. Department of Veterans Affairs and U.S. Department of Defense clinical practice guideline for the primary care management of chronic kidney disease

Schwartz AR, Sosnov J, Brown J, et al.
Ann Intern Med. Pub. online 30 Dec 2025.

Leggi

Gennaio 19, 2026 Alice Lione

EMA and FDA set common principles for AI in medicine development

14 gennaio 2026

Leggi

Gennaio 19, 2026 Alice Lione

Teplizumab treatment for stage 2 type 1 diabetes: a real-world evaluation of metabolic and immunological outcomes

Karakus KE, Chesshir L, Walker S, et al.
Diabetologia. Pub. online 15 Jan 2026.

Leggi

Gennaio 19, 2026 Alice Lione

Weight regain after cessation of medication for weight management: systematic review and meta-analysis

West S, Scragg J, Aveyard P, et al.
BMJ. Pub. online 7 Jan 2026.

Leggi

Gennaio 15, 2026 Alice Lione

FDA requests removal of suicidal behavior and ideation warning from glucagon-like peptide-1 receptor agonist (GLP-1 RA) medications: FDA’s evaluation did not identify an increased risk of suicidal ideation or behavior with the use of GLP-1 RA medications

13 gennaio 2026

Leggi

Gennaio 15, 2026 Alice Lione

European Commission: Teizeild (Teplizumab) is indicated to delay the onset of stage 3 type 1 diabetes (T1D) in adult and paediatric patients 8 years of age and older with stage 2 T1D

9 gennaio 2026

Leggi